| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 01/14/2010 | CA2730071A1 Antineoplastic derivatives of 4-oxo-l, 4-dihydro-quinolin?, preparation thereof, and therapeutic use thereof |
| 01/13/2010 | EP2142509A2 Quinolones and azaquinolones that inhibit prolyl hydroxylase |
| 01/13/2010 | EP2142508A2 Process for the preparation of sodium salt of l-(((l(r)-(3-(2-(7-chloro-2- quinolinyl)-ethenyl)phenyl)-3-(2-(l-hydroxy-l- methylethyl)phenyl)propyl)sulfanyl)methyl)cyclopropaneacetic acid |
| 01/13/2010 | EP1622873B1 Method for producing rac-1-{4-[2-hydroxy-3-(5-quinolyloxy)propyl]-piperazin-1-yl}-2,2-diphenylethan-1-one fumarate |
| 01/13/2010 | CN101624371A 4-carbostyril and 4H-1,4-benzothiazine derivatives and preparation method and application thereof |
| 01/12/2010 | US7645797 Gamma aminobutyric acid antagonist such as naphthylalanine; antiepileptic agents; antidepressants; anxiolytic agents; psychological disorders; neurodegenerative diseases; analgesics; drug withdrawal |
| 01/12/2010 | US7645780 N-[(1S,2R)-3-{[1-(3-bromophenyl)cyclopropyl]amino}-1-(3,5-difluorobenzyl)-2-hydroxypropyl]acetamide hydrochloride; for Alzheimer's disease; inhibitors of beta-secretase |
| 01/12/2010 | US7645779 Linked biaryl compounds |
| 01/12/2010 | US7645773 Thiazoles as inhibitors of 11β-hydroxysteroid dehydrogenase |
| 01/12/2010 | US7645760 1-(4-Benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives |
| 01/12/2010 | US7645759 (4-(S)-amino-5-(4-{4-[2,4-dichloro-3-(2,4-dimethyl-quinolin8yloxy-methyl) benzenesulfonylamino] tetrahydropyran-4carbonyl}-piperazin-1-yl)-5-oxo-pentyl] trimethyl-ammonium chloride, dihydrochloride; asthma or chronic bronchitis |
| 01/12/2010 | US7645757 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/12/2010 | CA2466338C New uses for anti-malarial therapeutic agents |
| 01/12/2010 | CA2387675C Novel hydronaphtalene compounds, prepared by a rhodium catalyzed ring opening reaction in the presence of phosphine ligand |
| 01/07/2010 | WO2010002483A1 Optionally condensed dihydro pyridine, dihydropyrimidine and dihydro pyrane derivatives acting as late sodium channel blockers |
| 01/07/2010 | WO2010001257A2 Novel solid state forms of laquinimod and its sodium salt |
| 01/07/2010 | WO2009050734A3 An industrially feasible process for the manufacture of bisquinoline derivatives by using substantially pure n-monosubstituted piperazines |
| 01/07/2010 | WO2008149168A8 Triazolo [1, 5-a] quinolines as adenosine a3 receptor ligands |
| 01/07/2010 | US20100004454 Quinolinium ion derivatives, process for the production of the derivatives, products made by using the same, and reduction and oxidation methods with the derivatives |
| 01/07/2010 | US20100004411 Polymerisation of ethylene and alpha-olefins with imino-quinolinol complexes |
| 01/07/2010 | US20100004271 Heterocyclic compounds as aganist for the thyroid receptor |
| 01/07/2010 | US20100004241 Non-imidazole aryloxyalkylamines |
| 01/07/2010 | US20100004222 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same |
| 01/07/2010 | US20100003216 HCV NS-3 Serine Protease Inhibitors |
| 01/07/2010 | US20100003196 Fluorescent membrane intercalating probes and methods for their use |
| 01/07/2010 | US20100001635 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/06/2010 | EP2140864A2 Use of GAL3 receptor antagonists for the treatment of depression and / or anxiety and compounds useful in such methods |
| 01/06/2010 | EP2140862A2 Use of GAL 3 receptor antagonists for the treatment of depression and /or anxiety and compounds useful in such methods |
| 01/06/2010 | EP2139886A1 Quinolone and tetrahydroquinoline and related compounds having nos inhibitory activity |
| 01/06/2010 | EP2139881A1 Quinolines and their therapeutic use |
| 01/06/2010 | EP2139860A2 Derivatives of the aminated hydroxyquinoline class for treating cancers |
| 01/06/2010 | CN100577647C 8-amidoquinaldine production method |
| 01/06/2010 | CN100577642C Aluminium and copper metallized insulated material |
| 01/06/2010 | CN100577633C CaSR antagonist |
| 01/05/2010 | US7642246 Pure rocuronium bromide |
| 01/05/2010 | CA2398113C Process for preparing quinolylacrylonitrile and intermediates therefor |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 12/31/2009 | US20090326232 Process for the Preparation of Leukotriene Receptor Antagonist (Montelukast Sodium) |
| 12/31/2009 | US20090326231 Process for the preparation of 8-hydroxy-5-[(1r)-1-hydroxy-2[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone monohydrochloride |
| 12/31/2009 | US20090326228 Compositions containing ionic liquids and their uses, in particular in organic synthesis |
| 12/31/2009 | US20090326058 CaSR Antagonist |
| 12/31/2009 | US20090326009 Novel 1-2-Dihydroquinoline Derivative Having Glucocorticoid Receptor Binding Activity |
| 12/31/2009 | US20090325962 Tyrosine derivative |
| 12/31/2009 | US20090325948 Inhibitors of undecaprenyl pyrophosphate synthase |
| 12/31/2009 | US20090325944 Methods and Compositions for Modulating Glycosylation |
| 12/31/2009 | US20090325912 Quinolinone derivatives and their pharmaceutical compositions |
| 12/31/2009 | US20090325900 Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 12/30/2009 | WO2009158467A2 Di-substituted phenyl compounds |
| 12/30/2009 | WO2009157418A1 Carboxylic acid compound |
| 12/30/2009 | WO2008155588A8 Sulfonyl-quinoline derivatives |
| 12/30/2009 | WO2008090517A3 Enriched plant extract, compound, and methods for the treatment of proliferative disorders |
| 12/30/2009 | EP2137155A1 Quinoline derivatives, pharmaceutical compositions comprising them, and their use in treating central nervous system and peripheral diseases |
| 12/30/2009 | EP1663976B1 4-pyridinylmethyl sulfonamide derivatives as fungicidal plant protection agents |
| 12/30/2009 | CN100575345C Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 12/30/2009 | CN100575330C Novel compounds |
| 12/30/2009 | CA2729227A1 2-heterocyclylaminoalkyl-(p-quinone) derivatives for treatment of oxidative stress diseases |
| 12/30/2009 | CA2729220A1 Di-substituted phenyl compounds |
| 12/30/2009 | CA2727340A1 Carboxylic acid compound |
| 12/29/2009 | US7638632 Aromatic and aromatic/heteroaromatic molecular structures with controllable electron conducting properties |
| 12/29/2009 | US7638630 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as VLA-4 inhibitors |
| 12/29/2009 | US7638533 Dihydro-1[1H]-quinolin-2-one derivatives as RXR agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 12/29/2009 | US7638519 Compounds, pharmaceutical compositions, and methods for the treatment of cardiovascular disease |
| 12/29/2009 | US7638513 inhibitors of matrix metalloproteinases, aggrecanases, tumor necrosis factor-alpha converting enzyme, and tumor necrosis factors |
| 12/29/2009 | US7638508 Glucocorticosteroid compound having anti-inflammatory activity |
| 12/29/2009 | CA2370250C Di-aryl acid derivatives as ppar receptor ligands |
| 12/29/2009 | CA2287214C Substituted benzopyran derivatives for the treatment of inflammation |
| 12/24/2009 | US20090318702 Process for production of 4-oxoquinoline compound |
| 12/24/2009 | US20090318495 Ethenyl carboxamide derivatives useful as microbiocides |
| 12/24/2009 | US20090318479 Substituted ring fused azines and their use in cancer therapy |
| 12/23/2009 | WO2009155362A1 Small molecule hematopoietic growth factor mimetic compounds and their uses |
| 12/23/2009 | WO2009153180A1 Heteroaromatic monoamides as orexinin receptor antagonists |
| 12/23/2009 | WO2009117381A3 Preparation of montelukast and its salts |
| 12/23/2009 | EP2134692A2 Quinoline derivatives and pharmaceutical compositions comprising them for selectin inhibition |
| 12/23/2009 | EP2134691A1 Quinolinone derivatives as parp and tank inhibitors |
| 12/23/2009 | EP2134681A1 Trans-annular rearrangement of active lactames |
| 12/23/2009 | EP2134678A2 N-(5, 6, 7, 8-tetrahydronaphthalen-1-yl) urea derivatives and related compounds as trpv1 vanilloid receptor antagonists for the treatment of pain |
| 12/23/2009 | EP1879564B1 Compounds to treat amyloidosis and prevent death of beta-cells in type 2 diabetes mellitus |
| 12/23/2009 | EP1817309B1 Acetamide compounds as fungicides |
| 12/23/2009 | CN101611011A Chemical compounds |
| 12/23/2009 | CN101611010A Process for the preparation of 8-hydroxy-5-[(1R)-1-hydroxy-2[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]-ethyl]-2(1H)-quinolinone monohydrochloride |
| 12/23/2009 | CN101611009A Quinoline derivatives |
| 12/23/2009 | CN101607973A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 12/23/2009 | CN101607937A Synthesis of 6-alkoxy-7-phenyl-4-hydroxy-3-quinoline carboxylic ester and application |
| 12/23/2009 | CA2726703A1 Heteroaromatic monoamides as orexinin receptor antagonists |
| 12/22/2009 | US7635704 Stable crystal of 4-oxoquinoline compound |
| 12/22/2009 | CA2538095C Selective androgen receptor modulators and methods of use thereof |
| 12/22/2009 | CA2529032C Processes for the preparation of 1-[2-benzimidazol-1-yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 12/22/2009 | CA2474460C Pyridine- and quinoline-derivatives |
| 12/22/2009 | CA2398138C Process for the preparation of quinolylpropenal |
| 12/17/2009 | WO2009151683A2 Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications |
| 12/17/2009 | WO2009150318A1 Novel 2-substituted quinoline derivatives, and method for preparing same |
| 12/17/2009 | WO2009149622A1 6-nitro acetophenone compounds, preparation methods and uses thereof |
| 12/17/2009 | US20090312546 Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors |
| 12/17/2009 | US20090312325 Quinoline Derivatives As Phosphodiesterase Inhibitors |
| 12/17/2009 | US20090312314 Heteroaromatic monoamides as orexinin receptor antagonists |
| 12/17/2009 | US20090312313 Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same |
| 12/16/2009 | EP2132180A1 Methods and compositions for selectin inhibition |
| 12/16/2009 | EP2132179A1 Process for preparing isomers of carmoterol |
| 12/16/2009 | EP1737812B1 Methods of amination |
| 12/16/2009 | EP1619180B1 CaSR ANTAGONIST |